Corporate Support ISAL XX 2027

The 20th international Symposium on ACUTE LEUKEMIAS (ISALXX) will be exclusively held in-person, again.

Take the opportunity and play an active role as the organizer of a Satellite Symposium or a Meet-the-Professor Session, or participate as an exhibitor and reach out for more than 800 AML health professionals from around the world. Take this face-to-face symposium and enjoy in-person connections to build visibility, introduce new products, and conduct product demonstrations.

In the 8 key areas

• Biology of Acute Leukemias
• Genetic and Molecular Characterization of AML
• Novel Markers for Diagnosis and Prognosis
• Novel Approaches and Targeted Therapies in AML
• Risk-adapted Therapy of AML and APL
• MRD in Acute Leukemias: Methods and Clinical Applications
• Immunotherapy for Acute Leukemias, including Transplantation
• ALL: Biology and Treatment Strategies

more than 80 speakers will again highlight in 11 Main Sessions the most advanced treatment strategies, products and services in AML today.

Why become an active part of ISALXX?

The organizers of ACUTE LEUKEMIAS XX (ISALXX) are happy to offer all corporate partners again a great variety of opportunities to actively support the international symposium ACUTE LEUKEMIAS XX, Munich, March 14-17, 2027, by fostering meaningful relationships, rendering the possibility to connect face-to-face with the leading international hematologists working in the field of AML and widening their on-site and digital presence.

The organizers highly value these partnerships and their important role that members of this community play by supporting the international symposium ACUTE LEUKEMIAS in their effort to provide hematologists with high quality educational sessions by simultaneously giving all attendees the opportunity to discuss the most recent findings in basic research and latest results of clinical studies with the internationally most renowned specialists in the field of AML.

Valuing all cooperating partners in their essential role and as an indispensible basis in driving research in the field of hematology forward, the Organising Office is aiming on creating individually tailored offers for all corporations and organizations to receive the greatest possible attention.

Sponsoring Options ISAL XX 2027

Play again an active role in ISALXX by joining ISALXX for impact.